SIGA Technologies Sees Unusually Large Options Volume (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the recipient of unusually large options trading activity on Wednesday. Investors purchased 1,200 call options on the company. This is an increase of 1,438% compared to the typical volume of 78 call options.

Hedge Funds Weigh In On SIGA Technologies

Several institutional investors have recently bought and sold shares of SIGA. DekaBank Deutsche Girozentrale purchased a new position in SIGA Technologies during the second quarter valued at $40,000. China Universal Asset Management Co. Ltd. grew its stake in SIGA Technologies by 64.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock valued at $93,000 after acquiring an additional 5,372 shares in the last quarter. Bayesian Capital Management LP purchased a new position in SIGA Technologies during the first quarter valued at $97,000. AQR Capital Management LLC purchased a new position in SIGA Technologies during the second quarter valued at $99,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in SIGA Technologies by 38.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after acquiring an additional 3,829 shares in the last quarter. 55.40% of the stock is owned by hedge funds and other institutional investors.

SIGA Technologies Price Performance

Shares of NASDAQ SIGA opened at $7.08 on Thursday. The firm has a fifty day moving average price of $7.58 and a 200-day moving average price of $8.12. The stock has a market cap of $505.29 million, a PE ratio of 6.05 and a beta of 0.90. SIGA Technologies has a 1 year low of $4.26 and a 1 year high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings data on Thursday, August 1st. The company reported $0.03 earnings per share (EPS) for the quarter. SIGA Technologies had a net margin of 48.55% and a return on equity of 51.40%. The firm had revenue of $21.81 million during the quarter. During the same period last year, the company earned ($0.04) earnings per share. On average, research analysts expect that SIGA Technologies will post 1.01 EPS for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.